JP6876434B2 - 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法 - Google Patents

蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法 Download PDF

Info

Publication number
JP6876434B2
JP6876434B2 JP2016542829A JP2016542829A JP6876434B2 JP 6876434 B2 JP6876434 B2 JP 6876434B2 JP 2016542829 A JP2016542829 A JP 2016542829A JP 2016542829 A JP2016542829 A JP 2016542829A JP 6876434 B2 JP6876434 B2 JP 6876434B2
Authority
JP
Japan
Prior art keywords
cell
cells
seq
fluorescent protein
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016542829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016529916A (ja
JP2016529916A5 (enExample
Inventor
ジュディス アグド
ジュディス アグド
ブライアン ブラウン
ブライアン ブラウン
Original Assignee
アイカーン スクール オブ メディシン アット マウント サイナイ
アイカーン スクール オブ メディシン アット マウント サイナイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイカーン スクール オブ メディシン アット マウント サイナイ, アイカーン スクール オブ メディシン アット マウント サイナイ filed Critical アイカーン スクール オブ メディシン アット マウント サイナイ
Publication of JP2016529916A publication Critical patent/JP2016529916A/ja
Publication of JP2016529916A5 publication Critical patent/JP2016529916A5/ja
Application granted granted Critical
Publication of JP6876434B2 publication Critical patent/JP6876434B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/30—Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2016542829A 2013-09-12 2014-09-12 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法 Active JP6876434B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361877120P 2013-09-12 2013-09-12
US61/877,120 2013-09-12
PCT/US2014/055492 WO2015038959A2 (en) 2013-09-12 2014-09-12 T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated t cells, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019211002A Division JP2020039353A (ja) 2013-09-12 2019-11-22 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法

Publications (3)

Publication Number Publication Date
JP2016529916A JP2016529916A (ja) 2016-09-29
JP2016529916A5 JP2016529916A5 (enExample) 2017-10-19
JP6876434B2 true JP6876434B2 (ja) 2021-05-26

Family

ID=52666523

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016542829A Active JP6876434B2 (ja) 2013-09-12 2014-09-12 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法
JP2019211002A Withdrawn JP2020039353A (ja) 2013-09-12 2019-11-22 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019211002A Withdrawn JP2020039353A (ja) 2013-09-12 2019-11-22 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法

Country Status (7)

Country Link
US (1) US11044896B2 (enExample)
EP (2) EP3043641B1 (enExample)
JP (2) JP6876434B2 (enExample)
AU (1) AU2014318520B2 (enExample)
CA (1) CA2922561C (enExample)
ES (1) ES2761280T3 (enExample)
WO (1) WO2015038959A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2761280T3 (es) * 2013-09-12 2020-05-19 Icahn School Med Mount Sinai Métodos de producción de animales transgénicos con receptores de células T que son específicos de una proteína fluorescente
KR20200006985A (ko) * 2017-05-12 2020-01-21 오거스타 유니버시티 리서치 인스티튜트, 인크. 인간 알파 태아단백-특이적 t 세포 수용체 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US6416971B1 (en) 1990-05-15 2002-07-09 E.R. Squibb & Sons, Inc. Soluble single chain T cell receptors
US5602307A (en) 1992-08-12 1997-02-11 Baylor College Of Medicine Non-human animal having predefined allele of a cellular adhesion gene
US5602299A (en) 1992-09-23 1997-02-11 Mount Sinai School Of Medicine Of The City University Of New York Transgenic animal models for neurodegenerative disease
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
JPH07132033A (ja) 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
US6066778A (en) 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
GB9930616D0 (en) 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
WO2006132524A1 (en) 2005-06-06 2006-12-14 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for generating a t cell against an antigen of interest.
ES2761280T3 (es) * 2013-09-12 2020-05-19 Icahn School Med Mount Sinai Métodos de producción de animales transgénicos con receptores de células T que son específicos de una proteína fluorescente

Also Published As

Publication number Publication date
CA2922561A1 (en) 2015-03-19
US11044896B2 (en) 2021-06-29
WO2015038959A2 (en) 2015-03-19
ES2761280T3 (es) 2020-05-19
EP3043641A4 (en) 2017-06-07
US20160219844A1 (en) 2016-08-04
AU2014318520B2 (en) 2020-09-03
WO2015038959A3 (en) 2015-06-04
JP2016529916A (ja) 2016-09-29
EP3043641B1 (en) 2019-09-11
CA2922561C (en) 2023-03-14
EP3610724A1 (en) 2020-02-19
AU2014318520A1 (en) 2016-03-31
EP3043641A2 (en) 2016-07-20
JP2020039353A (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
Shin et al. Generation of transgenic quail through germ cell‐mediated germline transmission
JP6004290B2 (ja) 不活化された内因性遺伝子座を有するトランスジェニックニワトリ
CN106536546A (zh) 表达人epo的经遗传修饰的非人动物
WO2012158986A2 (en) Methods for site-specific genetic modification in stem cells using xanthomonas tal nucleases (xtn) for the creation of model organisms
CN102199595A (zh) 表达盒、其转基因鱼及应用
JP6876434B2 (ja) 蛍光タンパク質に特異的なｔ細胞受容体を有する遺伝子導入動物の作製方法
JPWO2005054463A1 (ja) レトロトランスポゾンを用いた哺乳動物のゲノム改変技術の開発
CN106978416B (zh) 一种基因定位整合表达系统及其应用
JP6407507B2 (ja) 神経変性疾患関連タンパク質を神経細胞内で可視化したモデル動物
US12279600B2 (en) Genetically modified sterile avians and method for the reconstitution thereof
WO2006129696A1 (ja) 哺乳動物由来のＶａｓａホモログ遺伝子のプロモーター配列を含む発現ベクター及びその利用
JPWO2001033957A1 (ja) 細胞内のカルシウムイオンの濃度変化をモニターするトランスジェニック非ヒト哺乳動物
JP2005500835A (ja) Ｐｅｒｖスクリーニング法およびその使用
WO2001033957A1 (en) Transgenic non-human mammals for monitoring change in calcium ion concentration in cells
JP7203367B2 (ja) 哺乳動物細胞用遺伝子導入ベクター
RU2807599C2 (ru) Генетически модифицированные стерильные птицы и способ их воспроизводства
JP2024123352A (ja) 創薬スクリーニング方法及び脊椎動物細胞への遺伝子導入方法
Yan High efficiencies of gene delivery and gene targeting in embryonic stem cells of the fish medaka as a lower vertebrate model
OA19682A (en) Methods for gender determination of avian embryos in unhatched eggs and means thereof.
EP1624748A4 (en) TRANSGENIC ANIMAL MODEL FOR STEM OR TRANSGENIC CELLS
JP2007082446A (ja) トランスジェニック動物、その作出方法及びそのための核酸
WO2007007777A1 (ja) 蛍光性蛋白質の非蛍光性変異体を発現するトランスジェニック非ヒト哺乳動物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170911

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170911

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180802

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181031

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190722

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20191122

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20191204

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20191204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200108

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200730

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20201109

C28A Non-patent document cited

Free format text: JAPANESE INTERMEDIATE CODE: C2838

Effective date: 20201109

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210105

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210210

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210301

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210401

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210401

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210426

R150 Certificate of patent or registration of utility model

Ref document number: 6876434

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE

Ref document number: 6876434

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250